Literature DB >> 21959312

Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).

Marie-Claude Morice1, Ted E E Feldman, Michael J Mack, Elisabeth Ståhle, David R Holmes, Antonio Colombo, Marie-Angèle Morel, Marcel van den Brand, Patrick W Serruys, Friedrich Mohr, Didier Carrié, Gérard Fournial, Stefan James, Katrin Leadley, Keith D Dawkins, A Pieter Kappetein.   

Abstract

AIMS: The SYNTAX-LE MANS substudy prospectively evaluated 15-month angiographic and clinical outcomes in patients with treated left main (LM) disease. METHODS AND
RESULTS: In the SYNTAX trial, 1,800 patients with three-vessel and/or LM disease were randomised to either CABG or PCI; of these, 271 LM patients were prospectively assigned to receive a 15-month angiogram. The primary endpoint for the CABG arm was the ratio of ≥50% to <100% obstructed/occluded grafts bypassing LM lesions to the number placed. The primary endpoint for the PCI arm was the proportion of patients with ≤50% diameter stenosis ('patent' stents) of treated LM lesions. Per protocol, no formal comparison between CABG and PCI arms was intended based on the differing primary endpoints. Available 15-month angiograms were analysed for 114 CABG and 149 PCI patients. At 15 months, 9.9% (26/263) of CABG grafts were 100% occluded and an additional 5.7% (15/263) were ≥50% to <100% occluded. Overall, 27.2% (31/114) of patients had ≥1 obstructed/occluded graft. The 15-month CABG MACCE rate was 8.8% (10/114) and MACCE at 15 months was not significantly associated with graft obstruction/occlusion (p=0.85). In the PCI arm, 92.4% (134/145) of patients had ≤50% diameter LM stenosis at 15 months (89.7% [87/97] distal LM lesions and 97.9% [47/48] non-distal LM lesions). The 15-month PCI MACCE rate was 12.8% (20/156) and this was significantly associated with lack of stent patency at 15 months (p<0.001), mainly due to repeat revascularisation.
CONCLUSIONS: At 15 months, 15.6% (41/263) of grafts were at least 50% obstructed but this was not significantly associated with MACCE; 92.4% (134/145) of patients had stents that remained patent at 15 months, and stent restenosis was significantly associated with MACCE, predominantly due to revascularisation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959312     DOI: 10.4244/EIJV7I6A109

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Saphenous vein graft interventions.

Authors:  Emmanouil S Brilakis; Michael Lee; Julinda Mehilli; Konstantinos Marmagkiolis; Josep Rodes-Cabau; Rajesh Sachdeva; Anna Kotsia; George Christopoulos; Bavana V Rangan; Atif Mohammed; Subhash Banerjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

2.  The association between coronary graft patency and clinical status in patients with coronary artery disease.

Authors:  Mario Gaudino; Antonino Di Franco; Deepak L Bhatt; John H Alexander; Antonio Abbate; Lorenzo Azzalini; Sigrid Sandner; Garima Sharma; Sunil V Rao; Filippo Crea; Stephen E Fremes; Sripal Bangalore
Journal:  Eur Heart J       Date:  2021-04-07       Impact factor: 29.983

3.  Randomised, non-inferiority, controlled procedural outcomes TrIal comParing reverse T And Protrusion versus double-kissing and crush stenting: protocol of the TIP TAP I randomised trial.

Authors:  Kudrat Rakhimov; Andrea Buono; Remzi Anadol; Helen Ullrich; Maike Knorr; Majid Ahoopai; Thomas Münzel; Tommaso Gori
Journal:  BMJ Open       Date:  2020-06-16       Impact factor: 2.692

4.  Intravascular ultrasound-guided drug-eluting stent implantation for patients with unprotected left main coronary artery lesions: A single-center randomized trial.

Authors:  Xiao Ming Liu; Zuo Ming Yang; Xiao Kun Liu; Qi Zhang; Chang Qing Liu; Quan Le Han; Jian Hua Sun
Journal:  Anatol J Cardiol       Date:  2019-02       Impact factor: 1.596

5.  Single or multiple arterial bypass graft surgery vs. percutaneous coronary intervention in patients with three-vessel or left main coronary artery disease.

Authors:  Piroze M Davierwala; Chao Gao; Daniel J F M Thuijs; Rutao Wang; Hironori Hara; Masafumi Ono; Thilo Noack; Scot Garg; Neil O'leary; Milan Milojevic; Arie Pieter Kappetein; Marie-Claude Morice; Michael J Mack; Robert-Jan van Geuns; David R Holmes; Mario Gaudino; David P Taggart; Yoshinobu Onuma; Friedrich Wilhelm Mohr; Patrick W Serruys
Journal:  Eur Heart J       Date:  2022-03-31       Impact factor: 29.983

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.